Dr Julio Armando Rodriguez, MD in San Juan, PR - Medicare Ophthalmology

Dr Julio Armando Rodriguez, MD is a medicare enrolled "Ophthalmology" physician in San Juan, Puerto Rico. He went to University Of Puerto Rico School Of Medicine and graduated in 2001 and has 23 years of diverse experience with area of expertise as Ophthalmology. He is a member of the group practice Centro Oftalmologico Metropolitano Csp and his current practice location is 1250 Ave Jesus T Pinero, San Juan, Puerto Rico. You can reach out to his office (for appointments etc.) via phone at (787) 781-2565.

Dr Julio Armando Rodriguez is licensed to practice in Puerto Rico (license number 14810) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1215978366.

Contact Information

	Dr Julio Armando Rodriguez, MD
	1250 Ave Jesus T Pinero, San Juan, PR 00921-1616
	(787) 781-2565
	(787) 782-9524

Physician's Profile

Full Name	Dr Julio Armando Rodriguez
Gender	Male
Speciality	Ophthalmology
Experience	23 Years
Location	1250 Ave Jesus T Pinero, San Juan, Puerto Rico
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Julio Armando Rodriguez attended and graduated from University Of Puerto Rico School Of Medicine in 2001

NPI Data:

NPI Number: 1215978366
Provider Enumeration Date: 06/09/2006
Last Update Date: 02/05/2019

Medicare PECOS Information:

PECOS PAC ID: 4284643149
Enrollment ID: I20060613000043

Medical Identifiers

Medical identifiers for Dr Julio Armando Rodriguez such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1215978366	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	14810 (Puerto Rico)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Centro Oftalmologico Metropolitano Csp	4587655204	16

News Archive

Researchers identify possible trigger of chronic inflammation in people with diabetes

Inflammation is one of the main reasons why people with diabetes experience heart attacks, strokes, kidney problems and other, related complications. Now, in a surprise finding, researchers at Washington University School of Medicine in St. Louis have identified a possible trigger of chronic inflammation.

Takeda San Francisco and Pieris enter Anticalin scaffold technology collaboration

Takeda San Francisco (TSF) and Pieris AG have signed a drug discovery partnership agreement under which Pieris will apply its Anticalin(R) scaffold technology to deliver protein therapeutic candidates to Takeda, both companies announced today. The deal initially will focus on first-in-class drug discovery efforts around a predetermined Takeda target.

Racial and ethnic minorities, women, and the elderly were less likely to enroll in cancer clinical trials than whites, men, and younger patients

According to background information provided by the authors, "Ten years have passed since Congress responded to concerns about unequal access to clinical trials and enacted the National Institutes of Health (NIH) Revitalization Act, which encouraged representation of women and minority patients in NIH-sponsored research.

Prolactin reduces the levels of BCL6 protein and prevents aggressive breast cancer

Researchers from the Kimmel Cancer Center at Jefferson have found a mechanism by which a hormone responsible for milk production blocks an oncogene that makes breast cancer more aggressive.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Julio Armando Rodriguez allows following entities to bill medicare on his behalf.

Entity Name	Centro Oftalmologico Metropolitano Csp
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1528022027 PECOS PAC ID: 4587655204 Enrollment ID: O20040521000092

News Archive

Researchers identify possible trigger of chronic inflammation in people with diabetes

Takeda San Francisco and Pieris enter Anticalin scaffold technology collaboration

Racial and ethnic minorities, women, and the elderly were less likely to enroll in cancer clinical trials than whites, men, and younger patients

Prolactin reduces the levels of BCL6 protein and prevents aggressive breast cancer

Researchers from the Kimmel Cancer Center at Jefferson have found a mechanism by which a hormone responsible for milk production blocks an oncogene that makes breast cancer more aggressive.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Julio Armando Rodriguez is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Julio Armando Rodriguez, MD 1250 Ave Jesus T Pinero, San Juan, PR 00921-1616 Ph: (787) 781-2565	Dr Julio Armando Rodriguez, MD 1250 Ave Jesus T Pinero, San Juan, PR 00921-1616 Ph: (787) 781-2565

News Archive

Researchers identify possible trigger of chronic inflammation in people with diabetes

Takeda San Francisco and Pieris enter Anticalin scaffold technology collaboration

Racial and ethnic minorities, women, and the elderly were less likely to enroll in cancer clinical trials than whites, men, and younger patients

Prolactin reduces the levels of BCL6 protein and prevents aggressive breast cancer

Researchers from the Kimmel Cancer Center at Jefferson have found a mechanism by which a hormone responsible for milk production blocks an oncogene that makes breast cancer more aggressive.

Ophthalmology Doctors in San Juan, PR

Dr. Elena Maria Jimenez, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 735 Ave Ponce De Leon Ste 503, San Juan, PR 00917 Phone: 787-510-7880 Fax: 787-925-1200
Emilio A Arce-lopez, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 150 Ave De Diego, Suite 502, San Juan, PR 00907 Phone: 787-721-2142 Fax: 787-721-1882
Dr. Jose J De La Cruz-napoli, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 357 Ave De La Constitucion, San Juan, PR 00901 Phone: 787-289-6600 Fax: 787-289-6622
Ana Bartolomei, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 431 Calle Cesar Gonzalez, San Juan, PR 00918 Phone: 787-250-8285 Fax: 787-250-8445
Dr. Eli Samuel Rojas-diaz, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 420 Ponce De Leon Ave., Cond. Midtown Ste 801, San Juan, PR 00918 Phone: 787-753-9204 Fax: 787-751-2802
Dr. Maria H Berrocal-fernandez, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 150 Ave De Diego, Suite 404, San Juan, PR 00907 Phone: 787-725-9315 Fax: 787-724-4654
Juan Carlos Jimenez Perez, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 572 Calle Cesar Gonzalez, San Juan, PR 00918 Phone: 787-758-2404 Fax: 787-764-4227

Dr Julio Armando Rodriguez, MD - Medicare Ophthalmology in San Juan, PR

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Researchers identify possible trigger of chronic inflammation in people with diabetes

Takeda San Francisco and Pieris enter Anticalin scaffold technology collaboration

Racial and ethnic minorities, women, and the elderly were less likely to enroll in cancer clinical trials than whites, men, and younger patients

Prolactin reduces the levels of BCL6 protein and prevents aggressive breast cancer

Medicare Reassignments

Researchers identify possible trigger of chronic inflammation in people with diabetes

Takeda San Francisco and Pieris enter Anticalin scaffold technology collaboration

Racial and ethnic minorities, women, and the elderly were less likely to enroll in cancer clinical trials than whites, men, and younger patients

Prolactin reduces the levels of BCL6 protein and prevents aggressive breast cancer

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Researchers identify possible trigger of chronic inflammation in people with diabetes

Takeda San Francisco and Pieris enter Anticalin scaffold technology collaboration

Racial and ethnic minorities, women, and the elderly were less likely to enroll in cancer clinical trials than whites, men, and younger patients

Prolactin reduces the levels of BCL6 protein and prevents aggressive breast cancer

Ophthalmology Doctors in San Juan, PR